These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A micropatterned hepatocyte coculture model for assessment of liver toxicity using high-content imaging analysis. Trask OJ, Moore A, LeCluyse EL. Assay Drug Dev Technol; 2014; 12(1):16-27. PubMed ID: 24444127 [Abstract] [Full Text] [Related]
7. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes. Grimm FA, Iwata Y, Sirenko O, Bittner M, Rusyn I. Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751 [Abstract] [Full Text] [Related]
13. Stem-cell derived hepatocyte-like cells for the assessment of drug-induced liver injury. Donato MT, Tolosa L. Differentiation; 2019 Aug; 106():15-22. PubMed ID: 30844688 [Abstract] [Full Text] [Related]
14. Oxidative DNA damage contributes to usnic acid-induced toxicity in human induced pluripotent stem cell-derived hepatocytes. Gao X, Campasino K, Yourick MR, Cao Y, Yourick JJ, Sprando RL. J Appl Toxicol; 2024 Sep; 44(9):1329-1346. PubMed ID: 38724177 [Abstract] [Full Text] [Related]
15. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury. Goldring C, Antoine DJ, Bonner F, Crozier J, Denning C, Fontana RJ, Hanley NA, Hay DC, Ingelman-Sundberg M, Juhila S, Kitteringham N, Silva-Lima B, Norris A, Pridgeon C, Ross JA, Young RS, Tagle D, Tornesi B, van de Water B, Weaver RJ, Zhang F, Park BK. Hepatology; 2017 Feb; 65(2):710-721. PubMed ID: 27775817 [Abstract] [Full Text] [Related]
18. Evaluation of a Three-Dimensional Primary Human Hepatocyte Spheroid Model: Adoption and Industrialization for the Enhanced Detection of Drug-Induced Liver Injury. Schofield CA, Walker TM, Taylor MA, Patel M, Vlachou DF, Macina JM, Vidgeon-Hart MP, Williams A, McGill PJ, Newman CF, Sakatis MZ. Chem Res Toxicol; 2021 Dec 20; 34(12):2485-2499. PubMed ID: 34797640 [Abstract] [Full Text] [Related]
19. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles. Zhang J, Doshi U, Suzuki A, Chang CW, Borlak J, Li AP, Tong W. Chem Biol Interact; 2016 Aug 05; 255():3-11. PubMed ID: 26581450 [Abstract] [Full Text] [Related]